Viewing Study NCT06256432


Ignite Creation Date: 2025-12-24 @ 10:02 PM
Ignite Modification Date: 2026-02-25 @ 7:04 PM
Study NCT ID: NCT06256432
Status: RECRUITING
Last Update Posted: 2025-01-30
First Post: 2024-02-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal Syndrome
Sponsor: Noorik Biopharmaceuticals AG
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module